Dr. Benigno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
980 Johnson Fy Rd NE
Ste 130
Atlanta, GA 30342Phone+1 404-300-2990Fax+1 404-300-2986
Education & Training
- University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1973 - 1974
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Obstetrics and Gynecology, 1965 - 1969
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Transitional Year, 1964 - 1965
- Georgetown University School of MedicineClass of 1964
Certifications & Licensure
- GA State Medical License 1975 - 2021
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Ovarian Cancer Vaccine for Patients in Remission Start of enrollment: 2010 Jul 01
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 73 citationsMachine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.Cai Huang, Evan A. Clayton, Lilya V. Matyunina, L. DeEtte McDonald, Benedict B. Benigno
Scientific Reports. 2018-11-06 - 1609 citationsNiraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor Raza Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner
The New England Journal of Medicine. 2016-10-07 - 172 citationsGene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cellsNathan J. Bowen, L. DeEtte Walker, Lilya V. Matyunina, Sanjay Logani, Kimberly A Totten
BMC Medical Genomics. 2009-12-29
Press Mentions
- Multi-Algorithm Approach Helps Deliver Personalized Medicine for Cancer PatientsOctober 27th, 2021
- Choices for Second-Line Maintenance TherapyJuly 30th, 2019
- Maintenance and Recurrent Treatment Options for Ovarian CancerJuly 30th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: